FDA advisory committees
This article was originally published in The Tan Sheet
Executive Summary
Reps. John Dingell (D-Mich.), Henry Waxman (D-Calif.), Carlos Moorhead (R-Calif.) and Thomas Bliley (R-Va.) reportedly have drafted a letter to the Clinton Administration asking that FDA be allowed to retain its current roster of advisory committees. The letter is in response to an executive order from President Clinton that each department and agency terminate not less than one-third of its advisory committees.